Edwards Lifesciences (EW) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $92.01 -2.57%
EPS Growth %: +10.4%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: +10.4%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.64, $0.03 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Investing.com’s stocks of the week
- Arm Holdings stock sinks amid broad chip sector selloff
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
